IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.61M | 22.48M | 21.18M | 20.66M | 19.78M |
| Total Depreciation and Amortization | 1.43M | 1.17M | 980.40K | 794.30K | 785.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.76M | 5.06M | 2.45M | 2.39M | 1.18M |
| Change in Net Operating Assets | -854.10K | -3.76M | 399.60K | 3.30M | 4.28M |
| Cash from Operations | 28.95M | 24.95M | 25.01M | 27.14M | 26.03M |
| Capital Expenditure | -4.47M | -7.76M | -10.26M | -12.93M | -11.43M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -502.10K | -656.10K | -800.70K | -876.30K | -823.80K |
| Cash from Investing | -4.97M | -8.42M | -11.06M | -13.81M | -12.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 25.70K | 25.70K | 29.00K |
| Repurchase of Common Stock | -2.49M | -2.56M | -783.90K | -772.10K | -740.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.43M | -15.04M | -8.39M | -8.13M | -7.86M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.93M | -17.60M | -9.15M | -8.87M | -8.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 1.00K | 1.00K | 1.00K |
| Net Change in Cash | 6.04M | -1.07M | 4.81M | 4.46M | 5.20M |